Clinical value of offering multiple chemotherapy lines to a luminal-like metastatic breast cancer: A case report with eribulin.
Anna Amela ValsecchiJessica PaparoValeria PirroMatteo ManfrediMassimo Di MaioRossana DionisioPublished in: Tumori (2022)
This case report aims to emphasize the clinical value of a chronic chemotherapy treatment also in heavily pretreated and luminal-like metastatic breast cancer, supporting eribulin as a good choice to consider.